ERBB2 and gastric cancer: In addition, the survival analysis of CCL2 expression in HER2-negative GC patients (online supplemental figure 1D–F) and entire cohort of GC patients (online supplemental figure 1G–I) was also shown, which verified the negative effect of CCL2 on prognosis of GC patients, especially for HER2-positive GC patients.